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The lethal toxin (LT) from Clostridium sordellii is a glucosyltransferase that modifies and inhibits small G proteins of the
Ras family, Ras and Rap, as well as Rac proteins. LT induces cdc2 kinase activation and germinal vesicle breakdown (GVBD)
when microinjected into full-grown Xenopus oocytes. Toxin B from Clostridium difficile, that glucosylates and inactivates
Rac proteins, does not induce cdc2 activation, indicating that proteins of the Ras family, Ras and/or Rap, negatively regulate
cdc2 kinase activation in Xenopus oocyte. In oocyte extracts, LT catalyzes the incorporation of [14C]glucose into a group of
proteins of 23 kDa and into one protein of 27 kDa. The 23-kDa proteins are recognized by anti-Rap1 and anti-Rap2
antibodies, whereas the 27-kDa protein is recognized by several anti-Ras antibodies and probably corresponds to K-Ras.
Microinjection of LT into oocytes together with UDP-[14C]glucose results in a glucosylation pattern similar to the in vitro
glucosylation, indicating that the 23- and 27-kDa proteins are in vivo substrates of LT. In vivo time-course analysis reveals
that the 27-kDa protein glucosylation is completed within 2 h, well before cdc2 kinase activation, whereas the 23-kDa
proteins are partially glucosylated at GVBD. This observation suggests that the 27-kDa Ras protein could be the in vivo
target of LT allowing cdc2 kinase activation. Interestingly, inactivation of Ras proteins does not prevent the phosphoryla-
tion of c-Raf1 and the activation of MAP kinase that occurs normally around GVBD. © 1998 Academic Press
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INTRODUCTION
Full-grown stage VI Xenopus oocyte (Dumont, 1972) is
naturally arrested at the diplotene stage of meiotic
prophase; it contains a store of inactive pre-MPF5 formed of
cyclin B2 complexed with cdc2 which is maintained inac-
tive by two inhibitory phosphorylations on tyrosine 15 and
threonine 14 (Jessus and Ozon, 1993; Maller, 1994; Masui,
1992). It is assumed that in resting prophase oocyte, the two
protein kinases that phosphorylate tyrosine 15 and threo-
nine 14, respectively wee1 and myt1 protein kinases, are
fully active (Mueller et al., 1995a,b); in contrast, cdc25, the
dual protein phosphatase that catalyzes the reverse reac-
tion, is maintained inactive or prevented to interact with
pre-MPF, its only known substrate in oocyte (Izumi et al.,
1992; Jessus and Beach, 1992; Kumagai and Dunphy, 1992).
The physiological release of the prophase block, known as
meiotic maturation, occurs normally at ovulation under the
influence of progesterone, a follicular steroid hormone. The
biochemical pathway that allows the hormonal signal to
activate cdc25 phosphatase and/or to inhibit wee1 and
myt1 protein kinases has not yet been elucidated. The first
morphological event that characterizes the release of the
prophase block is the breakdown of the nuclear envelope
(germinal vesicle breakdown or GVBD) and the entry into
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M-phase of the first meiotic cell division. It takes place 3 to
6 h after progesterone stimulation and is inhibited by
protein synthesis inhibitors or by an elevated intracellular
level of cAMP (Jessus and Ozon, 1993; Maller, 1994; Masui,
1992). The roles and the identification of the different
newly synthetized proteins that are necessary for the induc-
tion of GVBD are not yet clearly defined and the cellular
targets of the cAMP-dependent protein kinase (PKA) are
still unknown.
On principle, any intracellular pathway that ultimately
converges toward the regulation of cdc25 phosphatase
and/or wee1 and myt1 protein kinases could be involved in
the activation of cdc2. Since the full-grown prophase-
arrested oocyte is a giant cell (diameter 1200 mm) that can
be easily isolated and microinjected, a number of studies
have used this cell as a model system to investigate the
possible in vivo involvement of different regulatory pro-
teins in the activation of cdc2 kinase. The effects of Ras
proteins have been particularly studied since Birchmeier et
al. (1985) showed for the first time that oncogenic
H-Rasval12 protein induces GVBD when microinjected into
Xenopus oocyte. In all these experiments, only mammalian
H-Ras has been tested, corresponding to the only Ras
subtype whose mRNA has not been found in the Xenopus
oocyte (Andeol et al., 1990; Baum and Bebernitz, 1990;
Spevak et al., 1993; Spindler et al., 1997). The amount of the
exogenous microinjected oncogenic Ras proteins necessary
to induce GVBD is high (10 to 50 ng per oocyte or an
intracellular concentration above 1 mM) (Barrett et al.,
1990; Birchmeier et al., 1985; Dudler and Gelb, 1996;
Nebreda et al., 1993; for review, Jessus et al., 1998). Fur-
thermore, the time course of Ras-induced GVBD is slow
when compared to the time course of progesterone-induced
maturation (more than 10 h versus 3 to 6 h). Therefore,
overexpression of oncogenic Ras protein could lead to the
activation of pre-MPF through a cellular signaling pathway
that is different from the signaling pathway activated by
progesterone (for review, Jessus et al., 1998). Some authors
reported that injection of oncogenic H-Ras is able to elicit
MPF and MAP kinase activation and GVBD in the presence
of protein synthesis inhibitors and in the absence of the
c-mos protein (Allende et al., 1988; Carnero and Lacal,
1995; Carnero et al., 1995; Daar et al., 1991; Kamata and
Kung, 1990; Nebreda et al., 1993). These results support the
model of an activation of the c-Raf1/MEK/MAP kinase
cascade by an elevated concentration of ectopic H-Ras,
leading to cdc2 activation independently of c-mos synthe-
sis.
In any case, this abundant literature does not allow one to
answer the major question concerning the roles, if any, of
endogenous Ras proteins in Xenopus oocytes. Two Ras
genes, K-Ras and N-Ras, have been cloned in Xenopus, and
both mRNAs have been shown to be present in oocyte
during oogenesis and early embryo (Andeol et al., 1990;
Baum and Bebernitz, 1990; Spevak et al., 1993; Spindler et
al., 1997). Ras proteins have also been detected in oocytes
with anti-Ras antibodies (Andeol et al., 1990; Davis and
Sadler, 1992; Deshpande and Kung, 1987; Hanocq-Quertier
and Hanocq, 1991; Korn et al., 1987).
It has been recently discovered that the lethal toxin (LT)
from Clostridium sordellii is a glucosyltransferase that
glucosylates and inactivates small G proteins of the Ras
subfamily, Ras, Rap, and Rac (Just et al., 1996; Popoff et al.,
1996). LT is the first toxin that inactivates Ras proteins in
intact cells (Just et al., 1996; Popoff et al., 1996); it repre-
sents a new powerful biochemical tool to explore the
biological functions of Ras at different phases of the cell
cycle. This prompted us to study the biological effect of LT
in prophase-arrested oocytes which are naturally synchro-
nized just before entry into the first meiotic division.
Microinjection of LT into oocytes catalyzes in ovo the
glucosylation of Ras proteins but also of other small G
proteins. Furthermore and to our surprise, LT induces
GVBD and activation of cdc2 kinase together with the
activation of the MAP kinase cascade. Altogether, these
results show that a small G protein that is an in vivo
substrate of LT negatively regulates cdc2 activation in
prophase-arrested Xenopus oocytes.
MATERIALS AND METHODS
Materials
Xenopus laevis adult females (CNRS, Rennes, France) were bred
and maintained under laboratory conditions. [35S]methionine,
UDP-[14C]glucose, and [g-32P]ATP were obtained from DuPont
NEN. Reagents, unless otherwise specified, were from Sigma.
Clostridium sordellii LT and Clostridium difficile toxin B were
purified as described respectively by Popoff (1987) and Von Eichel-
Streiber et al. (1987).
Oocyte Treatments
Isolated oocytes were prepared as described by Jessus et al.
(1987). Fully grown stage VI oocytes (Dumont, 1972), referred as
“prophase oocytes,” were induced to mature by addition of 1 mM
progesterone. Maturing oocytes were referred as germinal vesicle
breakdown (GVBD) stage when a white spot surrounded by a
pigmented ring appeared at the animal pole of the oocyte. Stage
IV oocytes (diameter 0.8 mm) (Dumont, 1972) were selected by
measuring diameter with an ocular micrometer. Oocyte enucle-
ation was performed as described by Jessus et al. (1989). C.
sordellii LT and C. difficile toxin B were diluted at different
concentrations in 10 mM Hepes, pH 7.4, before microinjection
of 50 nl of each toxin. In some experiments, oocytes were
transferred for 1 h in a medium containing 100 mg/ml cyclohex-
imide (CHX) or 1 mM of 3-isobutyl-1-methylxanthine (IBMX)
before microinjection. Cytological analysis was performed as
described by Rime et al. (1994).
In Vitro Glucosylation of Oocyte Extracts
One hundred prophase oocytes were homogenized in lysis buffer
(50 mM triethanolamine, 2 mM MgCl2, 150 mM KCl, 1 mM DTT,
5 mM GDP, 0.1 mM PMSF, 10 mg/ml leupeptin, pH 7.8) and
centrifuged at 15,000g at 4°C for 15 min (Sigma 302K). The 15,000g
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supernatant was used for in vitro glucosylation. In some cases, the
15,000g supernatant was collected and centrifuged at 100,000g at
4°C for 1 h in a TL100 Beckman centrifuge (TLA-100 rotor).
Supernatants (15,000g and 100,000g) and pellet (100,000g) were
then used for in vitro glucosylation. The glucosylation assay was
also performed with the in vitro translated Xenopus K-Ras. Briefly,
30 ml of UDP-[14C]glucose in ethanol (20 mCi/ml, 300 mCi/mmol;
DuPont NEN) was dried down under vacuum. Twenty microliters
of oocyte supernatants or resuspended pellet or reticulocyte lysate
containing Xenopus K-Ras was added with UDP-[14C]glucose and
toxins (80 mg/ml LT or toxin B in the extract) and incubated for 1 h
at 37°C. Reaction was stopped by adding Laemmli sample buffer
(Laemmli, 1970) and boiling. Samples (5 oocyte equivalent) were
then electrophoresed on a 15% SDS–polyacrylamide gel (Laemmli,
1970). The gel was treated with Amplify (Amersham), dried, and
autoradiographed.
In Vivo Glucosylation
A mixture of 0.33 mg/ml LT and 3 nCi UDP-[14C]glucose was
microinjected into each prophase oocyte. Microinjected oocytes
were then homogenized, centriguged at 15,000g for 15 min at 4°C,
and supernatants were electrophoresed on a 15% SDS–
polyacrylamide gel (Laemmli, 1970) and autoradiographed after
Amplify treatment (Amersham).
Histone H1 Kinase Assay and Immunoblotting
Histone H1 kinase assays were performed on p13 Sepharose-
bound extracts (3 oocytes equivalent) as previously described by
Rime et al. (1995). For Western blot analysis, samples of 3 to 9
oocytes were analyzed. Proteins were electrophoresed on a 10% or
15% SDS–PAGE gel (Laemmli, 1970; Anderson et al., 1973) and
transferred to nitrocellulose filters (Schleicher and Schull) using a
semidry blotting system (Millipore) as described by Jessus et al.
(1991). Two anti-Ras antibodies, one anti-Rap1 antibody, and one
anti-Rap2 antibody were used: a polyclonal anti-human Ras anti-
body (6275, 1:200 dilution; provided by Dr J. de Gunzburg, Institut
Curie Paris, France), a monoclonal anti-Ras antibody (Y13-259;
1:200 dilution; Oncogene Science), and polyclonal anti-human
Rap1 and Rap2 antibodies (1:200 dilution; provided by Dr J. de
Gunzburg, Institut Curie Paris, France). Polyclonal anti-Ras, anti-
Rap1, and anti-Rap2 antibodies as well as anti-mos (1:1000 dilu-
tion, Santa Cruz Biotechnology, C237) and anti-Raf1 (1:250 dilu-
tion, Santa Cruz Biotechnology, C-20) antibodies were revealed
with HRP–protein A (Amersham). Monoclonal Y13-259 anti-Ras
antibody was revealed with HRP–protein G (Amersham). Anti-
MAP kinase (1:3000 dilution, anti ERK1, Santa Cruz) antibody was
revealed with HRP-conjugated donkey anti-rabbit antibody (1:
10,000 dilution, DAKO). ECL Western blotting detection system is
from NEN.
In Vitro Translation of the Xenopus K-Ras Protein
pBluescript vector containing the coding sequence of Xenopus
K-Ras cDNA (Andeol et al., 1990) was subjected to a coupled
transcription/translation system (TnT-coupled reticulocyte lysate
system, Promega) in the presence or in the absence of [35S]methi-
onine. The corresponding vector without insert was used as con-
trol.
RESULTS
Microinjection of LT Activates cdc2 Kinase and
Induces Entry into M Phase
Two doses of purified LT, 8 or 16 ng, were microinjected
into prophase-arrested stage VI oocytes (Dumont, 1972).
Both injected doses of LT induced 100% GVBD as judged by
the appearance of a white spot at the animal hemisphere of
the oocyte (Fig. 1A). Induction of GVBD by LT microinjec-
FIG. 1. LT induces GVBD and activates cdc2 kinase. (A) GVBD
induction. Prophase oocytes were either treated with 1 mM proges-
terone as a positive control (E) or microinjected with either 0.33
mg/ml LT (F) or 0.167 mg/ml LT (h) or preincubated for 1 h in the
presence of CHX before LT (0.33 mg/ml) microinjection (n) or
preincubated for 1 h in the presence of IBMX before LT (0.33
mg/ml) microinjection (). GVBD was scored at regular times. (B)
cdc2 kinase activation. Cdc2 activity was assayed at different times
after GVBD, either after 0.167 mg/ml LT microinjection (F) or after
1 mM progesterone addition (h).
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tion is highly reproducible since it was obtained in oocytes
isolated from more than 10 different females. The intracel-
lular concentration of the toxin that is sufficient to induce
the biological activity is around 4–8 ng per oocyte, i.e., an
intracellular concentration of about 60 nM. At the dose of 8
ng per oocyte, the time course of white spot appareance is
comparable to the time course of progesterone-induced
GVBD (Fig. 1A). In some experiments, a lower dose of 4 ng
per oocyte is also able to induce GVBD. Interestingly, at the
highest dose tested (16 ng), the lag period between LT
microinjection and GVBD is shortened (Fig. 1A), indicating
that the intracellular effect of the toxin is time- and
dose-dependent. When protein synthesis is inhibited by
cycloheximide, LT is unable to induce GVBD (Fig. 1A).
Similarly, when the intracellular cAMP level is increased
by inhibiting cAMP phosphodiesterase by IBMX, LT-
induced GVBD is blocked (Fig. 1A). It can be concluded that
LT effects, like progesterone effects, are dependent upon the
PKA pathway and on newly synthetized proteins. During
progesterone-induced oocyte maturation, cdc2 kinase activ-
ity increases abruptly just prior GVBD; after a transient
drop, it reincreases at time of the metaphase I–metaphase II
transition (Huchon et al., 1993; Roy et al., 1991; Thibier et
al., 1997). The fluctuation of cdc2 kinase follows a similar
pattern in LT-microinjected oocytes (Fig. 1B).
A cytological analysis showed that LT induces GVBD and
formation of a metaphase spindle localized in the oocyte
cortex (Fig. 2). However, in contrast to oocytes that are
treated with progesterone, more than 60% of LT-
microinjected oocytes undergo pigment perturbations 3 to
4 h after the white spot appearance, suggesting that late
steps of the maturation process are perturbed.
LT Activates the MAP Kinase Pathway
During progesterone-induced maturation, a number of
protein kinases are activated in addition to cdc2, just prior
to or at GVBD (Jessus and Ozon, 1993). However, it is
unclear whether the majority of these kinases are activated
upstream, at the same time, or downstream after the
activation of cdc2. Nevertheless, it was important to inves-
tigate whether they were activated in response to LT
around the time of GVBD. Figure 3A shows that c-mos
kinase synthesis is induced following LT microinjection.
The faint band that is recognized in prophase extracts
probably corresponds to a nonspecific cross-reactive protein
since it is also detected in activated eggs (not shown) where
mos is supposed to be absent. Following LT microinjection,
Raf1 kinase is phosphorylated and MAP kinase is activated
(Figs. 3B and 3C), as judged by the changes in their electro-
phoretic mobility (Galaktionov et al., 1995; Thibier et al.,
1997). A kinetic study indicates that these events occur
when oocytes reach GVBD, but not during the 5-h lag
period that precedes GVBD (Fig. 3D). Therefore, the major
kinases that are phosphorylated and activated following
progesterone exposure similarly switch on around the time
of GVBD after LT microinjection.
LT Catalyzes in Vitro and in Vivo Glucosylation of
Low-Molecular-Mass Proteins (23 to 27 kDa)
LT is a glucosyltransferase that glucosylates and inacti-
vates Ras, Rac, and Rap proteins (Just et al., 1996; Popoff et
al., 1996). It was therefore important to identify which
proteins are targets of LT in Xenopus intact oocytes. In the
first in vitro approach, we incubated oocyte extracts
(15,000g supernatant) in the presence of LT and UDP-
[14C]glucose. As shown in Fig. 4A, LT catalyzes the incor-
poration of [14C]glucose into several proteins. The major
radioactive band migrates with apparent molecular mass of
about 23 kDa (Fig. 4A) and can be resolved into two or three
bands under our electrophoresis conditions. The second
labeled band migrates as a singlet of 27 kDa (Fig. 4A).
Identical patterns of in vitro glucosylation are observed
when extracts from immature small growing stage IV
oocytes (Dumont, 1972) or from metaphase II-arrested oo-
cytes were incubated in the presence of LT and UDP-
[14C]glucose (Fig. 4A). This indicates that the levels of major
substrates of LT do not vary, neither during late oogenesis
nor during meiotic maturation. Oocyte extracts were also
fractionated by high-speed centrifugation: the in vitro sub-
strates of LT distribute between the cytosol fraction and the
100,000g membrane pellet (Fig. 4B). However, the 27-kDa
band is enriched in the membrane pellet, whereas the
FIG. 2. Cytological analysis of LT-injected oocytes. Prophase oocytes were microinjected with LT (0.33 mg/ml) and were fixed 3 h after
GVBD. (A) Phase contrast. (B) Hoe¨chst dye staining. Bar, 10 mm.
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23-kDa triplet is predominantly recovered in the superna-
tant that contains predominantly soluble proteins (Fig. 4B).
Prophase oocytes can be manually enucleated. To eluci-
date if the nucleoplasm could contain small G proteins that
could be involved in LT action, manually isolated nuclei
(nuclear envelope and nucleoplasm) were incubated in the
presence of LT and UDP-[14C]glucose. No incorporation of
[14C]glucose can be detected when 5 nuclei are analyzed by
autoradiography. Moreover, the incorporation patterns of
nucleated and enucleated oocytes are quantitatively and
qualitatively identical (Fig. 4C). When 100 manually iso-
lated nuclei are analyzed, a faint radioactive band migrating
at 23 kDa can be detected (Fig. 4C). Therefore, if nuclear
small G proteins are substrates of LT, they represent a very
minor part of the LT substrates within the cell. It has been
reported that in Xenopus egg extracts, the nuclear small G
protein Ran, that is involved in nuclear trafficking (Bischoff
and Ponstingl, 1991a,b), can interfere with cdc2 activation
(Clarke et al., 1995; Kornbluth et al., 1994). The 23-kDa
glucosylated nuclear band that can be detected in oocyte
nuclei (Fig. 4C) does not migrate as the 28-kDa Ran protein.
Moreover, Ran is not glucosylated by LT in vitro (P. Boquet,
personal communication). Finally, LT microinjection pro-
motes cdc2 activation within 4 h in manually enucleated
oocytes, as progesterone does (Fig. 7B), demonstrating that
LT action does not require the nuclear compartment. Our
results clearly eliminate the possibility that endogenous
Ran protein could be involved in the biological effect of LT
in oocytes.
To elucidate if the glucosylation of small G proteins by
LT occurs also in vivo, we next microinjected 16 ng of LT
together with UDP-[14C]glucose. Oocytes were homoge-
FIG. 3. LT induces c-mos synthesis, Raf1 phosphorylation, and
MAP kinase activation. (A) Western blot with an anti-mos anti-
body. (B) Western blot with an anti-MAP kinase antibody. (C)
Western blot with an anti-Raf1 antibody. In A, B, and C: lanes 1,
control prophase oocytes; lanes 2: oocytes collected at time of
GVBD after progesterone treatment; lanes 3, oocytes collected at
time of GVBD after LT (0.08 mg/ml) microinjection. (D) Western
blots with an anti-MAP kinase antibody or with an anti-Raf1
antibody, as indicated. Oocytes were selected at different times
after microinjection of LT (0.08 mg/ml). In this experiment, GVBD
occurred 5 h after LT injection. MII, metaphase II-blocked oocytes.
FIG. 4. In vitro and in vivo glucosylation by LT. (A) Glucosylation
by LT. Extracts from stage IV oocytes (lanes 1 and 2), stage VI
oocytes (lanes 3 and 4), and metaphase II oocytes (lanes 5 and 6),
were incubated with UDP-[14C]glucose in the absence (lanes 1, 3,
and 5) or in the presence (lanes 2, 4, and 6) of LT and then
electrophoresed and autoradiographed. Lanes 7 and 8: prophase
oocytes were microinjected with UDP-[14C]glucose in the presence
(lane 7) or absence (lane 8) of LT. Oocytes were homogenized 6 h
after the injection (2 h 30 min after GVBD in the presence of LT)
and oocyte extracts were then electrophoresed and autoradio-
graphed. (B) Lysates of prophase oocytes were centrifuged at
15,000g. The 15,000g supernatant was then centrifuged at
100,000g. The 15,000g supernatant (lane 1), the 100,000g superna-
tant (lane 2), or the resuspended 100,000g pellet (lane 3) was
incubated in the presence of LT and UDP-[14C]glucose and then
electrophoresed and autoradiographed. (C) Extracts from 5 control
nucleated oocytes (lane 1), 5 enucleated oocytes (lane 2), and 100
nuclei (lane 3) were incubated with UDP-[14C]glucose and LT and
then electrophoresed and autoradiographed.
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nized 2 h after GVBD (6 h after LT microinjection in this
experiment) and extracts were then electrophoresed and
autoradiographed. A long period of exposure (3 months) was
required to reveal the radioactive proteins, as is also the
case for in vivo glucosylation by LT in mammalian cells.
This is explained by the limited amount of the intracellular
LT imposed by the microinjection experiment. However,
the pattern of in vivo labeled proteins is identical to the
pattern obtained after in vitro glucosylation (Fig. 4A, lane
7). No incorporation of [14C]glucose can be detected in these
proteins when UDP-[14C]glucose was microinjected in the
absence of LT (Fig. 4A, lane 8). Our results indicate that LT
glucosylates the same substrates in vivo and in vitro.
To test whether these proteins are fully in vivo glucosy-
lated, intact oocytes were microinjected with LT; 4 h later,
at the time of GVBD, oocytes were homogenized and oocyte
extracts were further in vitro incubated in the presence of
LT and UDP-[14C]glucose. Under these conditions, the in
vitro labeling of the 27-kDa protein is totally abolished and
the in vitro incorporation in the 23-kDa bands is decreased
by about 80% (Fig. 5A).
We then investigated the time course of the in vivo
glucosylation of the 27- and 23-kDa proteins. Prophase
oocytes were first microinjected with LT in the absence of
radioactivity. In this typical experiment, GVBD started 3 h
30 min and was completed 6 h after LT injection. At
different times after LT injection, oocytes were homoge-
nized and extracts were in vitro incubated in the presence of
LT and UDP-[14C]glucose. The in vitro incorporation of
[14C]glucose into the 27-kDa band is reduced faster than the
labeling of the 23-kDa proteins (Fig. 5B). The strong de-
crease in the in vitro incorporation of radioactivity into the
27-kDa cannot be accounted for by the degradation of the
27-kDa protein, since the protein is present in matured
oocytes (Fig. 4A, lane 6) and its proteolysis is not induced by
LT injection (Fig. 4A, lane 7). The in vivo glucosylation of
the 27-kDa protein is completed within 2 h after LT
injection since at that time in vitro [14C]glucose incorpora-
tion cannot be detected. In contrast, the 23-kDa proteins are
not yet fully glucosylated 4 h after LT injection (Fig. 5B).
This result indicates that the 23-kDa proteins are not yet
totally inhibited at the time of GVBD, whereas the 27-kDa
band is already fully inhibited 2 h before GVBD. This result
suggests that the glucosylation of the 27-kDa protein could
be the crucial event leading to cdc2 activation.
Ras, Rap, and Rac Proteins, the Potential LT
Substrates, Are Present in the Oocyte
Altogether these results show that a small G protein, an
in vivo and in vitro substrate of LT, negatively regulates
FIG. 5. In vitro glucosylation reactions after an in vivo LT
treatment. (A) Prophase oocytes were microinjected with control
buffer (lane 1) or with 0.33 mg/ml LT (lane 2). Four hours later (time
of GVBD for LT-injected oocytes), oocyte extracts were prepared,
then incubated in the presence of LT and UDP-[14C]glucose, and
electrophoresed and autoradiographed. (B) Prophase oocytes were
microinjected with 0.33 mg/ml LT. At different times following
the injection, oocyte extracts were prepared, incubated in the
presence of LT and UDP-[14C]glucose, and then electrophoresed
and autoradiographed.
FIG. 6. Ras and Rap proteins are expressed in the Xenopus
prophase oocyte. (A) Western blots of prophase oocytes with an
anti-Rap1 antibody (lane 1), with an anti-Rap2 antibody (lane 2),
with the monoclonal Y13-259 anti-Ras antibody (lane 4), and with
the polyclonal 6275 anti-Ras antibody (lane 6). Human oncogenic
H-Ras Val12 was loaded as a positive control and revealed by the
Y13-259 antibody (lane 3) or by the polyclonal 6275 antibody (lane
5). (B) Production of recombinant Xenopus K-Ras protein. A
coupled transcription/translation system was supplemented by
either a control pBluescript vector without any insert (lane 1) or a
pBluescript vector containing the coding sequence of Xenopus
K-Ras cDNA (lane 2) and [35S]methionine. Proteins were separated
on SDS–PAGE and the gel was then submitted to autoradiography.
(C) In vitro glucosylation of recombinant Xenopus K-Ras protein. A
coupled transcription/translation system was supplemented by
either a control pBluescript vector without any insert (lane 1) or a
pBluescript vector containing the coding sequence of Xenopus
K-Ras cDNA (lane 2) in the absence of radioactive amino acids.
Both reactions were then subjected to an in vitro glucosylation
assay in the presence of UDP-[14C]glucose and LT and then
electrophoresed and autoradiographed.
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activation of cdc2 kinase. An important task is to identify
this/these protein(s). So far, the only known substrates of
LT are Ras, Rac, and Rap proteins (Just et al., 1996; Popoff
et al., 1996). The biological effect of LT might depend upon
the inhibition of any of these proteins if present in the
oocytes.
Immunoblotting with a highly specific antibody raised
against human Rap1 reveals an unique band at the 23-kDa
position (Fig. 6A), showing that the Xenopus oocyte con-
tains an endogenous Rap1-like protein. A specific anti-Rap2
antibody also reveals a single band at the same position (Fig.
6A).
We then used two different anti-Ras antibodies, the
monoclonal antibody Y13-259 and a polyclonal anti-human
Ras antibody (6275, provided by Dr. J. de Gunzburg). The
monoclonal anti-Ras antibody (Y13-259) reveals a band at
27 kDa (Fig. 6A). It has been previously shown that the
Y13-259 anti-Ras antibody recognizes all forms of Ras and
recognizes in oocyte extracts one protein whose molecular
weight has been estimated around 24–28 kDa, depending
on the reports (Andeol et al., 1990; Davis and Sadler, 1992;
Deshpande and Kung, 1987). A second polyclonal anti-
human Ras antibody (6275, provided by Dr J. de Gunzburg)
also recognizes a major 27-kDa band by Western blotting
(Fig. 6A). These results strongly argue that the 27-kDa band
which is glucosylated by LT corresponds to endogenous Ras
proteins, either K-Ras or N-Ras. We were not able to deplete
the endogenous Ras proteins by imunoprecipitation despite
the extensive use of detergents, suggesting that Ras proteins
are included in membrane complexes that prevent the
accessibility of Ras toward the antibodies. Only small
amounts of the Ras protein which migrates at 27 kDa and is
in vitro glucosylated by LT (not shown) are immunoprecipi-
tated. We therefore used another approach to ascertain that
the 27-kDa band contains Ras protein.
Xenopus K-Ras mRNA was translated in a reticulocyte
lysate system in the presence of [35S]methionine. The in
vitro translation of Xenopus K-Ras gives rise to a radio-
active doublet of the 25- to 27-kDa band (Fig. 6B). The in
vitro translation was then performed in the absence of
radioactivity and the expressed proteins were submitted
to an in vitro glucosylation assay in the presence of LT
and UDP-[14C]glucose. Under these conditions, the 25- to
27-kDa doublet is glucosylated (Fig. 6C). Altogether,
these results show that K-Ras, the main Ras subtype of
the oocyte, migrates at 27 kDa and is an in vitro substrate
of LT.
Rac2 is a 22-kDa protein which has been detected in
oocyte extracts by immunoblotting, whereas Rac1 is not
detectable in the same extracts (Rooney et al., 1996).
Therefore, among the known substrates of LT, Ras, Rap1,
Rap2, and Rac2 are present at the protein level in the
oocyte. The 27-kDa LT-glucosylated band most probably
corresponds to a Ras protein, either K-Ras or N-Ras. The
23-kDa group could include Rap1, Rap2, and Rac2.
Rac Proteins Are Not Involved in LT Action
To test whether inhibition of Rac2 is involved in LT-
induced GVBD, we used another toxin, toxin B from C.
difficile, that glucosylates Rho subfamily proteins, and
among them Rac and CDC42 proteins (Just et al., 1995).
Toxin B was microinjected into prophase oocytes in parallel
with LT. While LT induces GVBD and cdc2 kinase activa-
tion, toxin B does not (Figs. 7A and 7B). In contrast, toxin B
FIG. 7. Toxin B does not activate cdc2. (A) GVBD was estimated
7 h after either 0.33 mg/ml LT (LT) or 0.15 mg/ml toxin B (Tox B)
microinjection or after 1 mM progesterone addition (Pg) or in
control prophase oocytes (prophase). (B) Histone H1 kinase activity
was assayed 4 h after either 0.33 mg/ml LT (LT) or 0.15 mg/ml
toxin B (Tox B) microinjection or after 1 mM progesterone addition
(Pg) or in control prophase oocytes (prophase) or after 0.33 mg/ml
LT microinjection in enucleated oocytes (LT-nu) or after 1 mM
progesterone addition in enucleated oocytes (Pg-nu). (C) In vitro
glucosylation by toxins. Extracts from prophase oocytes were
incubated with UDP-[14C]glucose in the presence of toxin B (lane 1)
or in the absence of any toxin (lane 2) or in the presence of LT (lane
3) and then electrophoresed and autoradiographed.
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provokes a strong effect on the oocyte cytoskeleton. Two
hours after microinjection oocytes undergo an important
softening of the cytoplasm which leaks out the oocyte,
consistent with the known effect of toxin B in the disrup-
tion of the actin cytoskeleton (Just et al., 1994). After
incubation of oocyte extracts in the presence of toxin B and
UDP-[14C]glucose, several proteins with an apparent mo-
lecular mass ranging from 21 to 23 kDa were glucosylated,
most probably including Rac2 protein (Fig. 7C). Since only
LT, not toxin B, induces GVBD, it is possible to rule out an
effect of the inhibition of Rac2 in the regulation of cdc2
kinase in Xenopus oocytes. Then, the other proteins that
could be involved in the biological action of LT are Ras
and/or Rap proteins.
DISCUSSION
The end point of the progesterone signal transduction
pathway in amphibian oocyte is the activation of MPF or
cdc2 kinase. The reproducible induction of GVBD following
microinjection of LT establishes that the inhibition of (a)
small G protein(s) of the Ras family is sufficient to activate
cdc2 kinase and an apparently normal entry into M-phase of
the first meiotic division, as judged by a cytological analy-
sis. This unexpected observation shed new light on the
mechanisms that regulate oocyte maturation.
Which in Ovo Targets of LT Are Implicated in the
Repression of cdc2 Kinase?
Since toxin B does not activate cdc2 kinase following
microinjection into oocyte, a role for Rac or CDC42 pro-
teins can be ruled out. By immunoblotting with different
specific antibodies, Ras, Rap1, and Rap2 proteins can be
detected in oocyte extracts. At the mRNA level, K-Ras
(Andeol et al., 1990; Baum and Bebernitz, 1990) and N-Ras
(Spevak et al., 1993) have been previously characterized in
Xenopus oocyte. The cDNA clones corresponding to Xeno-
pus Rap2A and Rap2B have been isolated in our laboratory
and the Xenopus Rap1 cloning is under process (K. Suziede-
lis, unpublished data). Therefore, at least five proteins of the
Ras family (K-Ras, N-Ras, Rap1, Rap2A, Rap2B) are poten-
tial substrates of LT that could be involved in the regulation
of cdc2 kinase.
A 27-kDa protein that is recognized by two different
anti-Ras antibodies and is mainly associated with the
membranes is an in vivo and in vitro substrate of LT. Its
intracellular content could be estimated at 5 ng per oocyte.
It clearly does not correspond to Xenopus Rap1 and Rap2
proteins which migrate faster than the 27-kDa band on
SDS–PAGE and which probably belong to the 23-kDa
proteins that are in vivo glucosylated by LT. The 27-kDa
protein is totally glucosylated following LT microinjection
during the lag period that precedes cdc2 activation, whereas
the 23-kDa protein in vivo glucosylation is not yet com-
pleted at GVBD time. These observations favor the view
that the 27-kDa protein, which corresponds to an endoge-
nous Ras protein, could be the in vivo substrate of LT
responsible of its biological effect. The in vitro translation
experiments of Xenopus K-Ras mRNA argue, but do not
definitively prove, that the 27-kDa is a K-Ras. More work
will be necessary to further elucidate whether Rap1, Rap2,
and N-Ras proteins could play a role in LT-induced GVBD.
We are now producing constitutively active mutants of
these different Xenopus proteins to better analyze their
biological function.
Which Effectors Are Regulated by Small G Proteins
of the Ras Family?
It is well established that GTP-bound Ras can interact
with multiple target enzymes at the level of cell mem-
branes. The best characterized Ras effectors in somatic cells
are the Raf family of protein Ser/Thr kinases acting up-
stream the MAP kinase cascade (Downward, 1997). The
inhibition of endogenous Ras proteins by LT in Xenopus
oocyte does not prevent the activation of this pathway since
c-Raf1 is phosphorylated and MAP kinase is activated at the
time of GVBD. This rules out the possibility that LT could
act through a precocious activation of the MAP kinase
pathway. Strikingly, since LT catalyzes the in vivo glucosy-
lation and therefore inactivates the endogenous Ras pro-
teins before GVBD and before the full activation of MAP
kinase and phosphorylation of c-Raf1, it may be concluded
that endogenous Ras proteins are not necessarily involved
in the activation of the MAP kinase cascade that can take
place in the absence of active Ras proteins. This does not
mean that Ras proteins cannot activate the MAP kinase
cascade in the oocyte; indeed, numerous studies have
shown that overexpression of oncogenic human H-Ras
activates in vitro and in ovo MAP kinase and consequently
cdc2 kinase through an unknown downstream mechanism
(reviewed by Jessus et al., 1998). Our results, demonstrating
that inhibition of oocyte Ras proteins induces cdc2 activa-
tion, together with the well-established induction of GVBD
by oncogenic mammalian H-Ras, lead to a paradox: inhibi-
tion or activation of similar proteins induces the same
biological effect. A provocative hypothesis resolving the
paradox would be that the mammalian oncogenic H-Ras
acts as a dominant negative, thus leading to inhibition of
endogenous Ras. However, it must be noted from the
literature that only microinjections of high doses (1 to 6
mM) of the oncogenic version of memmalian H-Ras which
corresponds to the only Ras subtype whose mRNA has
never been found in Xenopus oocytes have been performed.
They induce MPF activation through an intracellular path-
way that is clearly different from the physiological pathway
activated by progesterone (reviewed by Jessus et al., 1998).
The exogenous oncogenic mammalian H-Ras could there-
fore activate in the oocyte the MAP kinase pathway that
ultimately leads to cdc2 activation, whereas the endoge-
nous wild-type Xenopus N- or K-Ras would act on different
effectors. Therefore, both paradoxical results can be easily
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reconciled if it is admitted that, depending on the Ras type,
on the intracellular concentration of the protein, and/or on
its localization, different effectors are controlled.
Then, what could be the effector of endogenous Ras
proteins that negatively regulates cdc2 kinase? Interest-
ingly, it has been reported that injection of different anti-
Ras antibodies into the oocyte accelerates the time course
of progesterone-induced maturation and furthermore par-
tially inhibits adenylate cyclase activity measured in vitro
on oocyte membrane fractions (Sadler et al., 1986). Al-
though it was reported that oncogenic H-Ras does not
modify the oocyte cAMP level (Birchmeier et al., 1985), the
possibility that endogenous small G proteins of the Ras
family (K-Ras, N-Ras, or Rap proteins) might regulate
adenylate cyclase cannot be dismissed. A type IX adenylate
cyclase has been recently cloned in Xenopus and its mRNA
shown to be present in the oocyte (Torrejon et al., 1997).
The regulation of this enzyme is unknown so far and
speculation is not excluded that it could be a target for
endogenous Ras proteins in the oocyte. Therefore, as is the
case of Saccharomyces cerevisiae where RAS1 and RAS2
proteins positively regulate adenylate cyclase (Broek et al.,
1985; Toda et al., 1985), it is possible that the oocyte
adenylate cyclase is similarly regulated directly or undi-
rectly by endogenous Ras. Interestingly, it has been re-
ported that overexpression of Xenopus N-Ras in S. cerevi-
siae decreases the cAMP level (Spevak et al., 1993).
Therefore, in S. cerevisiae, expression of two proteins of the
Ras family has opposite effects on the cAMP level, support-
ing the view that each Ras subtype could exert a specific
control at the level of the effectors. This observation
supports the possibility that the oocyte cAMP level which
plays a major function in oocyte maturation could be
controlled by endogenous small G proteins from the Ras
family.
Biological Functions of Ras Proteins in the Oocyte
As already mentioned, at least five proteins of the Ras
family are present in the Xenopus oocyte and it cannot be
excluded that new members will be discovered. Why are so
many proteins of the same family in a single cell? The
oocyte acquires its competence to fertilization and devel-
opment during a long-lasting period called oogenesis. Dur-
ing this period, a number of cell functions need to be highly
regulated:
1. the arrest of the cell cycle at the diplotene stage of
meiotic prophase, corresponding to a G2/M arrest;
2. the accumulation of molecules necessary for the fu-
ture development of the fertilized oocyte;
3. the acquisition of a molecular pathway that allows the
oocyte to respond to an extracellular signal liberated from
the follicular cells by resuming meiotic maturation; it
corresponds to the acquisition of the progesterone-
transduction pathway in the case of the amphibian oocyte;
4. protection from apoptosis.
For these cell functions, cell cycle checkpoint, growth,
response to extracellular signal, and apoptosis, small G
proteins of the Ras family have been shown to play major
pivotal roles, either agonistic or antagonistic depending on
cell types (Downward, 1997, 1998). It would not be unex-
pected that the oocyte utilizes this family of regulatory
molecules to coordinate in a single cell these different
biological activities.
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